Bob Kronemyer

Dr. Matt Davidson, Ph.D., wanted to find an effective and affortable treatment for the recurring common warts on his hands, which has lead him to become one of the youngest, if not youngest, pharmaceutical company pioneers in the country. 

Reimbursements for actinic keratosis treatments are down slightly, but the demand for treatment is up by 20 percent.

Topical 5‐fluorouracil is FDA-approved to treat actinic keratoses and superficial basal cell carcinoma, but it is commonly used off-label to treat a number of other skin conditions, such as squamous cell carcinoma despite strong evidence.

Literature review shows that laser-assisted photodynamic therapy more efficacious than photodynamic therapy alone for actinic keratosis.

Adults with severe and mostly active atopic eczema are at a higher risk of developing cardiovascular disease, a population-based study shows.

Physicians bypass systemic treatments in moderate to severe cases of atopic dermatitis despite its potential to control symptoms.

Studies indicate physicians are fried, but a new review says it’s not as bad as it sounds.

Researcher experiments with reformulating psoriasis topical as a lotion instead of cream, which performed well with patients.

While botulinum toxin is most commonly used to relieve frowns and wrinkles, it is increasingly being shown to be associated with improving mood and relationships, a researcher says.

There are plenty of laser technologies for the practice, but then there are cornerstone lasers every practice should have. Learn more in this article from the Fall Clinical conference.

Topical 5-fluorouracil (5-FU), which is FDA approved for treating actinic keratoses and superficial basal cell carcinoma, shows the strongest evidence of effectiveness for these two conditions plus squamous cell carcinoma, according to a comprehensive systematic review.

Two approved and two pending anti-IL 23 drugs offer an opportunity for moderate to severe psoriasis patients to regain their lives, according to researchers presenting at the 2018 Fall Clinical Dermatology Conference.

Reporting from Fall Clinical in Las Vegas, Dr. James Del Rosso reviews best practices for topical therapy uses in psoriasis and atopic dermatitis.

Study finds daylight photodynamic therapy with ablative fractional laser more effective than with microdermabrasion for treating actinic keratoses with large area field cancerization.

Dupilumab-associated conjunctivitis may warrant discontinuing therapy for atopic dermatitis, a study shows.

Atopic dermatitis patients are likely more willing to adhere to treatment and achieve better outcomes when there is shared decision-making between the clinician and patient, according to an article in press in the Annals of Allergy, Asthma and Immunology.

Congress has proposed two bills that are designed to promote a "scientific exchange" between drug manufacturers and physcians. As a result, drug manufacturers may be able to share clinical data and non-FDA-approved uses of drugs with healthcare providers in the future.

Combination treatment of dupilumab and topical corticosteroid treatment improved itch, mood and quality of life in adult patients with moderate-to-severe atopic dermatitis, according to a new trial.

The distribution of localized infantile hemangiomas of the face and scalp favor involvement of the midline face, scalp and ocular axis, shows a retrospective review published in the journal Pediatric Dermatology.

Discordance between increase in billed procedures vs increase in number of patients.

The biologic dupilumab is projected to be a cost-effective treatment for moderate-to-severe atopic dermatitis, shows a new study.  (©Dzm1try/Shutterstock.com)

Topical vitamin A provides no benefit in treating atopic dermatitis, whereas topical vitamin D may actually exacerbate symptoms, according to an evidence-based review.

When it comes to successfully diagnosing melanonychia ― a brown or black pigmentation of the nail unit – it is important to examine the nails, look for pigmented lesions, be suspicious of nail melanoma, and biopsy early rather than late.

Mapping the human genome for chronic itch holds the potential to develop targeted therapy for atopic dermatitis and psoriasis itch, a study shows.

The Food and Drug Administration is in the process of evaluating scientific data on the safety of probiotics and postbiotics in cosmetics, said Linda Katz, M.D., director of the Office of Cosmetics and Color for the FDA.

Study shows that blocking IL-13 improves atopic dermatitis ― a promising finding for IL-13 atopic dermatitis drugs in development.

In speaking at the 2018 AAD Summer Meeting in Chicago, one doctor recommends that dermatologists in training learn more about diagnosing and treating STDs due to increasing prevalence.

Patients with moderate-severe atopic dermatitis are at high risk of having inadequate disease control, according to a cross-sectional study in JAMA Dermatology.

Study finds the combination of duplilumab and topical corticosteroids works in hard-to-treat atopic dermatitis cases in adult patients.

 Physicians writing in the Journal of the American Academy of Dermatology say that physicians should counter the proliferation of fake news on climate change.